A controversial argument about our healthcare system is a microcosm of the ongoing political circus in the United States. In the upcoming 2012 election, we can expect sulfuric acid to rise quickly. Compared with other developed countries, medical expenses per capita in China are double. The current system is dysfunctional, expenditure increases every year and is expected to put incredible pressure on our vulnerable economy. Most medical expenses are for patients with chronic illness, many of which can be prevented.
In Yemen, the epidemic from 2016 has a more typical origin. The epidemic is caused by the collapse of the national health system and the weak water and sanitation infrastructure. This situation is exacerbated by persistent conflicts causing 14.5 million malnutrition and lack of access to clean drinking water. Scientists understand the spread of diseases by simulating the occurrence of historical cholera. Despite its role as one of the oldest diseases to annoy humans, the world is still facing a massive cholera epidemic. Countries in the United States and other countries where water and sanitation systems are well developed may not be faced with cholera, but it is important to recognize that the cost of illness is low in developing countries. For health and sanitation workers in countries like Yemen and Haiti, the fight with cholera is continuing
Healthcare systems often do not interact effectively with other elements of the public health system due to its history, structure, and especially the intense competition in the health care market that has evolved since the collapse of medical reforms in the early 1990s . This report explains the government public health agencies in particular. Structures and incentives for health care are technology and process driven and do not support the time of research and reflection, communication and external relations, which are often needed to effectively prevent illness and promote health. Often the state health department regulates access to healthcare providers and buyers' markets and often has legal authority to set the insurance reimbursement rate for public and private providers and purchasers.